A Case-Control Association Study of RANTES (-28C>G) Polymorphism as a Risk Factor for Parkinson’s Disease in Isparta, Turkey

Background. Recent studies have revealed that inflammatory processes are involved in the pathogenesis of Parkinson’s disease (PD). Multiple lines of evidence have suggested that chemokines and their receptors are involved in several neurodegenerative disorders. We have examined whether genetic polym...

Full description

Saved in:
Bibliographic Details
Main Authors: Nilufer Sahin-Calapoglu, Serpil Demirci, Mustafa Calapoglu, Baris Yasar
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Parkinson's Disease
Online Access:http://dx.doi.org/10.1155/2016/5042604
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552043439456256
author Nilufer Sahin-Calapoglu
Serpil Demirci
Mustafa Calapoglu
Baris Yasar
author_facet Nilufer Sahin-Calapoglu
Serpil Demirci
Mustafa Calapoglu
Baris Yasar
author_sort Nilufer Sahin-Calapoglu
collection DOAJ
description Background. Recent studies have revealed that inflammatory processes are involved in the pathogenesis of Parkinson’s disease (PD). Multiple lines of evidence have suggested that chemokines and their receptors are involved in several neurodegenerative disorders. We have examined whether genetic polymorphisms at the genes encoding chemokines IL-8 (-251A>T), MCP-1 (-2518A/G), and RANTES (-28C>G) and chemokine receptors CCR2 (V64I) and CCR5 (-Δ32) were associated with sporadic PD risk in Isparta, Turkey. Method. The pilot case-control association study included 30 PD patients and 60 control subjects, who were all genotyped with PCR-RFLP for the five polymorphisms. Their genotype and haplotype frequencies were compared statistically. Results. One SNP (-28C>G) in RANTES revealed a significant association with PD (P (allele) < 0.0001, p-trend = 0.0007). The risk allele (G) in the homozygous and dominant models (OR = 17.29 and 32.10, 95% CI = 0.86–347.24 and 1.74–591.937, resp.) suggests additional PD risk. The haplotype TGCAN from the IL-8 (-251A>T), MCP-1 (-2518A>G), RANTES (-28C>G), CCR-2 (V64I), and CCR-5 (-Δ32) has protective effect (OR = 0.08 [CI = 0.01–0.63], p=0.019). Conclusions. Our data are the first indication of the role of RANTES (-28C>G) in PD risk.
format Article
id doaj-art-baf9d2fc26314cb08b44046269b9e641
institution Kabale University
issn 2090-8083
2042-0080
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Parkinson's Disease
spelling doaj-art-baf9d2fc26314cb08b44046269b9e6412025-02-03T05:59:43ZengWileyParkinson's Disease2090-80832042-00802016-01-01201610.1155/2016/50426045042604A Case-Control Association Study of RANTES (-28C>G) Polymorphism as a Risk Factor for Parkinson’s Disease in Isparta, TurkeyNilufer Sahin-Calapoglu0Serpil Demirci1Mustafa Calapoglu2Baris Yasar3Department of Medical Biology, Faculty of Medicine, Süleyman Demirel University, Isparta, TurkeyDepartment of Neurology, Faculty of Medicine, Süleyman Demirel University, Isparta, TurkeyDepartment of Biochemistry, Faculty of Science, Süleyman Demirel University, Isparta, TurkeyDepartment of Medical Biology, Faculty of Medicine, Süleyman Demirel University, Isparta, TurkeyBackground. Recent studies have revealed that inflammatory processes are involved in the pathogenesis of Parkinson’s disease (PD). Multiple lines of evidence have suggested that chemokines and their receptors are involved in several neurodegenerative disorders. We have examined whether genetic polymorphisms at the genes encoding chemokines IL-8 (-251A>T), MCP-1 (-2518A/G), and RANTES (-28C>G) and chemokine receptors CCR2 (V64I) and CCR5 (-Δ32) were associated with sporadic PD risk in Isparta, Turkey. Method. The pilot case-control association study included 30 PD patients and 60 control subjects, who were all genotyped with PCR-RFLP for the five polymorphisms. Their genotype and haplotype frequencies were compared statistically. Results. One SNP (-28C>G) in RANTES revealed a significant association with PD (P (allele) < 0.0001, p-trend = 0.0007). The risk allele (G) in the homozygous and dominant models (OR = 17.29 and 32.10, 95% CI = 0.86–347.24 and 1.74–591.937, resp.) suggests additional PD risk. The haplotype TGCAN from the IL-8 (-251A>T), MCP-1 (-2518A>G), RANTES (-28C>G), CCR-2 (V64I), and CCR-5 (-Δ32) has protective effect (OR = 0.08 [CI = 0.01–0.63], p=0.019). Conclusions. Our data are the first indication of the role of RANTES (-28C>G) in PD risk.http://dx.doi.org/10.1155/2016/5042604
spellingShingle Nilufer Sahin-Calapoglu
Serpil Demirci
Mustafa Calapoglu
Baris Yasar
A Case-Control Association Study of RANTES (-28C>G) Polymorphism as a Risk Factor for Parkinson’s Disease in Isparta, Turkey
Parkinson's Disease
title A Case-Control Association Study of RANTES (-28C>G) Polymorphism as a Risk Factor for Parkinson’s Disease in Isparta, Turkey
title_full A Case-Control Association Study of RANTES (-28C>G) Polymorphism as a Risk Factor for Parkinson’s Disease in Isparta, Turkey
title_fullStr A Case-Control Association Study of RANTES (-28C>G) Polymorphism as a Risk Factor for Parkinson’s Disease in Isparta, Turkey
title_full_unstemmed A Case-Control Association Study of RANTES (-28C>G) Polymorphism as a Risk Factor for Parkinson’s Disease in Isparta, Turkey
title_short A Case-Control Association Study of RANTES (-28C>G) Polymorphism as a Risk Factor for Parkinson’s Disease in Isparta, Turkey
title_sort case control association study of rantes 28c g polymorphism as a risk factor for parkinson s disease in isparta turkey
url http://dx.doi.org/10.1155/2016/5042604
work_keys_str_mv AT nilufersahincalapoglu acasecontrolassociationstudyofrantes28cgpolymorphismasariskfactorforparkinsonsdiseaseinispartaturkey
AT serpildemirci acasecontrolassociationstudyofrantes28cgpolymorphismasariskfactorforparkinsonsdiseaseinispartaturkey
AT mustafacalapoglu acasecontrolassociationstudyofrantes28cgpolymorphismasariskfactorforparkinsonsdiseaseinispartaturkey
AT barisyasar acasecontrolassociationstudyofrantes28cgpolymorphismasariskfactorforparkinsonsdiseaseinispartaturkey
AT nilufersahincalapoglu casecontrolassociationstudyofrantes28cgpolymorphismasariskfactorforparkinsonsdiseaseinispartaturkey
AT serpildemirci casecontrolassociationstudyofrantes28cgpolymorphismasariskfactorforparkinsonsdiseaseinispartaturkey
AT mustafacalapoglu casecontrolassociationstudyofrantes28cgpolymorphismasariskfactorforparkinsonsdiseaseinispartaturkey
AT barisyasar casecontrolassociationstudyofrantes28cgpolymorphismasariskfactorforparkinsonsdiseaseinispartaturkey